Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000019

Chief Regulatory Officer acquired 8,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schacterle Amy Chief Regulatory Officer 2025-01-06 Grant or award +8,800 8,800 D
Derivatives
Schacterle Amy Chief Regulatory Officer 2025-01-06 Grant or award · Employee Stock Option (right to buy) +13,200 13,200 D
Loading xslF345X05/wk-form4_1736298170.xml…